Skip to main content
Equibles

STATE STREET CORP

Position in TCRX — TScan Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$203,166
-$6,220 QoQ
Shares Held
207,313
0.0% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 60 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. TCRX ranks #340 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in TCRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $203,166 207,313
2026-03-31 $209,386 207,313
2025-12-31 $207,313 207,313
2025-09-30 $359,109 197,313
2025-06-30 $290,743 200,513
2025-03-31 $1,127,802 817,248
2024-12-31 $2,434,881 800,948
2024-09-30 $3,767,365 756,499
2024-06-30 $3,557,297 608,085
2024-03-31 $1,071,900 135,000
2023-12-31 $356,213 61,100
2023-09-30 $106,752 41,700
2023-06-30 $96,250 38,500
2023-03-31 $50,400 24,000
2022-12-31 $20,770 13,400
2022-09-30 $40,870 13,400
2022-06-30 $42,143 13,400
2022-03-31 $35,280 12,600
2021-12-31 $54,900 12,200
2021-09-30 $101,748 12,200